Table 1.
The main parameters of the participants
| Parameters | Patients with early ex in 15 days (N: 23) | Patients without early ex in 15 days (N: 176) |
|---|---|---|
| Age (Median, Range) | 63 (17-85) | 53 (16-86) |
| Gender (F/M) | 11/12 | 69/107 |
| Type of Disease (APL/non-APL/secondary to MDS/treatment-related) | 6/15/2/0 | 19/130/23/4 |
| Treatment type (Intensive treatment/non-intensive treatment/supportive treatment) | 14/4/5 | 153/13/10 |
| ECOG score (0/1/2/3/4) | 0/4/7/4/8 | 35/99/20/12/10 |
| ELN cytogenetic category (Favorable/non-favorable/unknown) | 7/4/12 | 75/43/58 |
| Charlson Index (2/3/4/5/6/7/8/9/10) | 7/2/6/1/4/3/0/0/0 | 67/28/26/31/10/8/2/3/1 |
| Hemoglobin at diagnosis (mg/dl) (median, range) | 8 (4-13) | 9 (4-16) |
| WBC at diagnosis (median, range) | 68.1×103/µl (0.9-200×103/µl) | 8.8×103/µl (0.6-300×103/µl) |
| Platelet at diagnosis (median, range) | 30×103/µl (5-478×103/µl) | 41×103/µl (4-400×103/µl) |
| LDH at diagnosis (U/L) | 1059 (370-3000) | 504.5 (160-16170) |